Search hospitals > Louisiana > Baton Rouge
Our Lady of the Lake Physicians Group - Medical Oncology
Claim this profileBaton Rouge, Louisiana 70809
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Colorectal Cancer
Conducts research for Non-Small Cell Lung Cancer
81 reported clinical trials
2 medical researchers
Summary
Our Lady of the Lake Physicians Group - Medical Oncology is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer and other specialties. Our Lady of the Lake Physicians Group - Medical Oncology is involved with conducting 81 clinical trials across 164 conditions. There are 2 research doctors associated with this hospital, such as David S. Hanson and Marshall P. Stagg.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
David S. HansonMary Bird Perkins Cancer Center4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
38 reported clinical trials
82 drugs studied
Marshall P. StaggLSU Health Baton Rouge-North Clinic4 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
38 reported clinical trials
83 drugs studied
Clinical Trials running at Our Lady of the Lake Physicians Group - Medical Oncology
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Pancreatic Cancer
Colon Cancer
Rectal Cancer
Anal Squamous Cell Carcinoma
Breast Cancer
Squamous Cell Carcinoma
Anal Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Our Lady of the Lake Physicians Group - Medical Oncology?
Our Lady of the Lake Physicians Group - Medical Oncology is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer and other specialties. Our Lady of the Lake Physicians Group - Medical Oncology is involved with conducting 81 clinical trials across 164 conditions. There are 2 research doctors associated with this hospital, such as David S. Hanson and Marshall P. Stagg.